U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C54H90N6O18
Molecular Weight 1111.3218
Optical Activity UNSPECIFIED
Defined Stereocenters 12 / 12
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of VALINOMYCIN

SMILES

CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C

InChI

InChIKey=FCFNRCROJUBPLU-DNDCDFAISA-N
InChI=1S/C54H90N6O18/c1-22(2)34-49(67)73-31(19)43(61)55-38(26(9)10)53(71)77-41(29(15)16)47(65)59-36(24(5)6)51(69)75-33(21)45(63)57-39(27(11)12)54(72)78-42(30(17)18)48(66)60-35(23(3)4)50(68)74-32(20)44(62)56-37(25(7)8)52(70)76-40(28(13)14)46(64)58-34/h22-42H,1-21H3,(H,55,61)(H,56,62)(H,57,63)(H,58,64)(H,59,65)(H,60,66)/t31-,32-,33-,34+,35+,36+,37-,38-,39-,40+,41+,42+/m0/s1

HIDE SMILES / InChI

Molecular Formula C54H90N6O18
Molecular Weight 1111.3218
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 12 / 12
E/Z Centers 0
Optical Activity UNSPECIFIED

Valinomycin is an ionophore and acts by creating an influx of K+ ions in bacterial cells. It is an antibiotic substance with wide range of activity against different bacteria, fungies and virus-infected cells. Also it demonstrates insecticide and nematocide properties. Because of its toxicity to eukaryotic cells, valinomycin cannot be used in human therapy.

Originator

Sources: DOI: 10.1002/cber.19550880111

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Activity of isosteviol lactone on mitochondrial metabolism.
2003-06-05
Calcium release from Synechocystis cells induced by depolarization of the plasma membrane: MscL as an outward Ca2+ channel.
2003-05
Transport of L-arginine and nitric oxide formation in human platelets.
2003-05
Activation of Akt is essential for acetylcholine to trigger generation of oxygen free radicals.
2003-04-01
Purified human MDR 1 modulates membrane potential in reconstituted proteoliposomes.
2003-04-01
Light-induced increase in free Mg2+ concentration in spinach chloroplasts: measurement of free Mg2+ by using a fluorescent probe and necessity of stromal alkalinization.
2003-04-01
Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.
2003-04
Matrix volume measurements challenge the existence of diazoxide/glibencamide-sensitive KATP channels in rat mitochondria.
2003-03-15
Application of the empirical force field to macrocyclic ion carriers, siderophores, and biomimetic analogs.
2003-03
Involvement of a Na+/HCO-3 cotransporter in mouse sperm capacitation.
2003-02-28
Active sulfate secretion by the intestine of winter flounder is through exchange for luminal chloride.
2003-02
Evidence for nucleotide-dependent passive H+ transport protein in the plasma membrane of barley roots.
2003-01
Phosphatidylserine content is a more important contributor than transmembrane potential to interactions of merocyanine 540 with lipid bilayers.
2002-12-23
Stimulation of voltage-dependent calcium channels during capacitation and by progesterone in human sperm.
2002-12-15
N-terminal domain of the dual-targeted pea glutathione reductase signal peptide controls organellar targeting efficiency.
2002-12-06
Artificial cell based on lipid hollow polyelectrolyte microcapsules: channel reconstruction and membrane potential measurement.
2002-11-01
Improved purification for thermophilic F1F0 ATP synthase using n-dodecyl beta-D-maltoside.
2002-11-01
Permeability transition-independent release of mitochondrial cytochrome c induced by valinomycin.
2002-11
Cyclic hexapeptide of D,L-alpha-aminoxy acids as a selective receptor for chloride ion.
2002-10-23
Rehydration of high-density sickle erythrocytes in vitro.
2002-10-15
Ferrous-iron-dependent uptake of L-glutamate by a mesophilic, mixotrophic iron-oxidizing bacterium strain OKM-9.
2002-10
Biochemical and biophysical properties of purified phospholipid vesicles containing bovine heart cytochrome c oxidase.
2002-10
Vesicle transmembrane potential is required for translocation to the cytosol of externally added FGF-1.
2002-09-02
Measurement of extracellular pH, K(+), and lactate in ischemic heart.
2002-09-01
Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells.
2002-09
Calcium uptake and calcium transporter expression by trophoblast cells from human term placenta.
2002-08-31
Photodynamic activation of ion transport through lipid membranes and its correlation with an increased dielectric constant of the membrane.
2002-08-19
Potassium-selective atomic force microscopy on ion-releasing substrates and living cells.
2002-08-15
Acetylcholine leads to free radical production dependent on K(ATP) channels, G(i) proteins, phosphatidylinositol 3-kinase and tyrosine kinase.
2002-08-15
Efflux of chromate by Pseudomonas aeruginosa cells expressing the ChrA protein.
2002-07-02
Evaluation of the separate equilibrium processes that dictate the upper detection limit of neutral ionophore-based potentiometric sensors.
2002-07-01
Mitochondrial sequestration and Ca(2+)-dependent release of cytosolic Zn(2+) loads in cortical neurons.
2002-07
Roles of the Na,K-ATPase alpha4 isoform and the Na+/H+ exchanger in sperm motility.
2002-07
The fetal and neonatal brain protein neuronatin protects PC12 cells against certain types of toxic insult.
2002-06-30
Measuring the dielectric properties of herpes simplex virus type 1 virions with dielectrophoresis.
2002-05-10
Ca(2+) influx through the osteoclastic plasma membrane ryanodine receptor.
2002-05
Valinomycin sensitivity proves that light-induced thylakoid voltages result in millisecond phase of chlorophyll fluorescence transients.
2002-04-22
ATP generation during reduced inorganic sulfur compound oxidation by Acidithiobacillus caldus is exclusively due to electron transport phosphorylation.
2002-04
Reconstitution of coupled fumarate respiration in liposomes by incorporating the electron transport enzymes isolated from Wolinella succinogenes.
2002-04
Effects of the ionophores valinomycin, ionomycin and gramicidin A on the element compartmentation in cultured rat hepatocytes.
2002-04
Evidence for a gamma-hydroxybutyrate (GHB) uptake by rat brain synaptic vesicles.
2002-03
Ferrous ion transport across chloroplast inner envelope membranes.
2002-03
Interference of MI-D, a new mesoionic compound, on artificial and native membranes.
2002-03
Sodium transport in triads isolated from rabbit skeletal muscle.
2002-02-01
Potentiometric estimation of the stability constants of ion-lonophore complexes in ion-selective membranes by the sandwich membrane method: theory, advantages, and limitations.
2002-02-01
Functional characterization of CitM, the Mg2+-citrate transporter.
2002-01-01
BCL-2 does not control programmed cell death in the IPLB-LdFB cell line from the insect Lymantria dispar.
2002
Profiling of drugs for membrane activity using liposomes as an in vitro model system.
2002
On-chip integration of sequential ion-sensing system based on intermittent reagent pumping and formation of two-layer flow.
2001-11-15
Participation of hyf-encoded hydrogenase 4 in molecular hydrogen release coupled with proton-potassium exchange in Escherichia coli.
2001
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
Valinomycin is a potent replication inhibitor of severe acute respiratory syndrome (SARS) (or similar) coronavirus (CoV) infections in Vero cells with an EC50 = 0.85 uM.
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:06:16 GMT 2025
Edited
by admin
on Mon Mar 31 22:06:16 GMT 2025
Record UNII
N561YS75MN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
VALINOMYCIN
HSDB   MI  
Common Name English
NSC-122023
Preferred Name English
ANTIBIOTIC N-329 B
Common Name English
IONOPHORE ANTIBIOTIC PRODUCED BY STREPTOMYCES FULVISSIMUS
Common Name English
CYCLIC(D-.ALPHA.-HYDROXYISOVALERYL-D-VALYL-L-LACTOYL-L-VALYL- D-.ALPHA.-HYDROXYISOVALERYL-D-VALYL-L-LACTOYL-L-VALYL-D-.ALPHA.- HYDROXYISOVALERYL-D-VALYL-L-LACTOYL-L-VALYL)
Systematic Name English
VALINOMYCIN [MI]
Common Name English
VALINOMYCIN [HSDB]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1976
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
Code System Code Type Description
HSDB
6423
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY
MESH
D014634
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY
PUBCHEM
3000706
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY
NSC
122023
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY
EPA CompTox
DTXSID9041150
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY
ECHA (EC/EINECS)
217-896-6
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY
DRUG BANK
DB14057
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY
MERCK INDEX
m11366
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY Merck Index
NCI_THESAURUS
C924
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY
FDA UNII
N561YS75MN
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY
CAS
2001-95-8
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY
WIKIPEDIA
VALINOMYCIN
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY
CHEBI
28545
Created by admin on Mon Mar 31 22:06:16 GMT 2025 , Edited by admin on Mon Mar 31 22:06:16 GMT 2025
PRIMARY
Related Record Type Details
TRANSPORTER -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY